The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8338383 B1

PDF
Full Text
Expired
Date of Patent:
Dec. 25, 2012

Filed:

Feb. 17, 2012
Applicants:

Daniel Tyree Gregory, Jr., Hampstead, NC (US);

Stephan Dale Glenn, Weston, FL (US);

Asher Nathan, Bet Shemesh, IL;

Inventors:

Daniel Tyree Gregory, Jr., Hampstead, NC (US);

Stephan Dale Glenn, Weston, FL (US);

Asher Nathan, Bet Shemesh, IL;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A61K 35/413 (2006.01);
U.S. Cl.
CPC ...
Abstract

A method for treating a cancer, by determining a patient to have an ECOG (Eastern Cooperative Oncology Group) score of 0 or 1 and selecting that patient for treatment, and administering to the patient an effective amount of an immunomodulating composition comprising small molecular weight components of less than 3000 daltons, and having the following properties: (i) is extracted from bile of animals; (ii) is capable of stimulating monocytes and/or macrophages; (iii) is capable of modulating tumor necrosis factor production and/or release; (iv) contains no measurable level of IL-1α, IL-1β, TNF, IL-6, IL-8, IL-4, GM-CSF or IFN-γ; (v) is not cytotoxic to human peripheral blood mononuclear cells; and (vi) is not an endotoxin. A method of increasing the survival rate of a cancer patient.


Find Patent Forward Citations

Loading…